Substituted reverse pyrimidine Bmi-1 inhibitors

Amine substituted reverse pyrimidine compounds and forms thereof that inhibit the function and reduce the level of B-cell specific Moloney murine leukemia virus integration site 1 (Bmi-1) protein and methods for their use to inhibit Bmi-1 function and reduce the level of Bmi-1 to treat a cancer medi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Cao, Liangxian, Paget, Steven D, Davis, Thomas W, Baiazitov, Ramil, Liu, Ronggang, Moon, Young-Choon, Sydorenko, Nadiya, Wilde, Richard Gerald, Lee, Chang-Sun, Du, Wu, Ren, Hongyu
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Cao, Liangxian
Paget, Steven D
Davis, Thomas W
Baiazitov, Ramil
Liu, Ronggang
Moon, Young-Choon
Sydorenko, Nadiya
Wilde, Richard Gerald
Lee, Chang-Sun
Du, Wu
Ren, Hongyu
description Amine substituted reverse pyrimidine compounds and forms thereof that inhibit the function and reduce the level of B-cell specific Moloney murine leukemia virus integration site 1 (Bmi-1) protein and methods for their use to inhibit Bmi-1 function and reduce the level of Bmi-1 to treat a cancer mediated by Bmi-1 are described herein.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11180483B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11180483B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11180483B23</originalsourceid><addsrcrecordid>eNrjZNAPLk0qLsksKS1JTVEoSi1LLSpOVSioLMrMzUzJzEtVcMrN1DVUyMzLyEzKLMkvKuZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfGhwYaGhhYGJhbGTkbGxKgBAFGZK0U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Substituted reverse pyrimidine Bmi-1 inhibitors</title><source>esp@cenet</source><creator>Cao, Liangxian ; Paget, Steven D ; Davis, Thomas W ; Baiazitov, Ramil ; Liu, Ronggang ; Moon, Young-Choon ; Sydorenko, Nadiya ; Wilde, Richard Gerald ; Lee, Chang-Sun ; Du, Wu ; Ren, Hongyu</creator><creatorcontrib>Cao, Liangxian ; Paget, Steven D ; Davis, Thomas W ; Baiazitov, Ramil ; Liu, Ronggang ; Moon, Young-Choon ; Sydorenko, Nadiya ; Wilde, Richard Gerald ; Lee, Chang-Sun ; Du, Wu ; Ren, Hongyu</creatorcontrib><description>Amine substituted reverse pyrimidine compounds and forms thereof that inhibit the function and reduce the level of B-cell specific Moloney murine leukemia virus integration site 1 (Bmi-1) protein and methods for their use to inhibit Bmi-1 function and reduce the level of Bmi-1 to treat a cancer mediated by Bmi-1 are described herein.</description><language>eng</language><subject>CHEMISTRY ; ELECTROTHERAPY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MAGNETOTHERAPY ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; RADIATION THERAPY ; ULTRASOUND THERAPY</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211123&amp;DB=EPODOC&amp;CC=US&amp;NR=11180483B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211123&amp;DB=EPODOC&amp;CC=US&amp;NR=11180483B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Cao, Liangxian</creatorcontrib><creatorcontrib>Paget, Steven D</creatorcontrib><creatorcontrib>Davis, Thomas W</creatorcontrib><creatorcontrib>Baiazitov, Ramil</creatorcontrib><creatorcontrib>Liu, Ronggang</creatorcontrib><creatorcontrib>Moon, Young-Choon</creatorcontrib><creatorcontrib>Sydorenko, Nadiya</creatorcontrib><creatorcontrib>Wilde, Richard Gerald</creatorcontrib><creatorcontrib>Lee, Chang-Sun</creatorcontrib><creatorcontrib>Du, Wu</creatorcontrib><creatorcontrib>Ren, Hongyu</creatorcontrib><title>Substituted reverse pyrimidine Bmi-1 inhibitors</title><description>Amine substituted reverse pyrimidine compounds and forms thereof that inhibit the function and reduce the level of B-cell specific Moloney murine leukemia virus integration site 1 (Bmi-1) protein and methods for their use to inhibit Bmi-1 function and reduce the level of Bmi-1 to treat a cancer mediated by Bmi-1 are described herein.</description><subject>CHEMISTRY</subject><subject>ELECTROTHERAPY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MAGNETOTHERAPY</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>RADIATION THERAPY</subject><subject>ULTRASOUND THERAPY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAPLk0qLsksKS1JTVEoSi1LLSpOVSioLMrMzUzJzEtVcMrN1DVUyMzLyEzKLMkvKuZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfGhwYaGhhYGJhbGTkbGxKgBAFGZK0U</recordid><startdate>20211123</startdate><enddate>20211123</enddate><creator>Cao, Liangxian</creator><creator>Paget, Steven D</creator><creator>Davis, Thomas W</creator><creator>Baiazitov, Ramil</creator><creator>Liu, Ronggang</creator><creator>Moon, Young-Choon</creator><creator>Sydorenko, Nadiya</creator><creator>Wilde, Richard Gerald</creator><creator>Lee, Chang-Sun</creator><creator>Du, Wu</creator><creator>Ren, Hongyu</creator><scope>EVB</scope></search><sort><creationdate>20211123</creationdate><title>Substituted reverse pyrimidine Bmi-1 inhibitors</title><author>Cao, Liangxian ; Paget, Steven D ; Davis, Thomas W ; Baiazitov, Ramil ; Liu, Ronggang ; Moon, Young-Choon ; Sydorenko, Nadiya ; Wilde, Richard Gerald ; Lee, Chang-Sun ; Du, Wu ; Ren, Hongyu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11180483B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>ELECTROTHERAPY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MAGNETOTHERAPY</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>RADIATION THERAPY</topic><topic>ULTRASOUND THERAPY</topic><toplevel>online_resources</toplevel><creatorcontrib>Cao, Liangxian</creatorcontrib><creatorcontrib>Paget, Steven D</creatorcontrib><creatorcontrib>Davis, Thomas W</creatorcontrib><creatorcontrib>Baiazitov, Ramil</creatorcontrib><creatorcontrib>Liu, Ronggang</creatorcontrib><creatorcontrib>Moon, Young-Choon</creatorcontrib><creatorcontrib>Sydorenko, Nadiya</creatorcontrib><creatorcontrib>Wilde, Richard Gerald</creatorcontrib><creatorcontrib>Lee, Chang-Sun</creatorcontrib><creatorcontrib>Du, Wu</creatorcontrib><creatorcontrib>Ren, Hongyu</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Cao, Liangxian</au><au>Paget, Steven D</au><au>Davis, Thomas W</au><au>Baiazitov, Ramil</au><au>Liu, Ronggang</au><au>Moon, Young-Choon</au><au>Sydorenko, Nadiya</au><au>Wilde, Richard Gerald</au><au>Lee, Chang-Sun</au><au>Du, Wu</au><au>Ren, Hongyu</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Substituted reverse pyrimidine Bmi-1 inhibitors</title><date>2021-11-23</date><risdate>2021</risdate><abstract>Amine substituted reverse pyrimidine compounds and forms thereof that inhibit the function and reduce the level of B-cell specific Moloney murine leukemia virus integration site 1 (Bmi-1) protein and methods for their use to inhibit Bmi-1 function and reduce the level of Bmi-1 to treat a cancer mediated by Bmi-1 are described herein.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US11180483B2
source esp@cenet
subjects CHEMISTRY
ELECTROTHERAPY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MAGNETOTHERAPY
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
RADIATION THERAPY
ULTRASOUND THERAPY
title Substituted reverse pyrimidine Bmi-1 inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T04%3A06%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Cao,%20Liangxian&rft.date=2021-11-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11180483B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true